Faculty

Lourdes Gonzalez Suarez, M.D., Ph.D.

Clinical Studies

Clinical Trial on the Use of Ravulizumab in Pregnancies complicated by Severe Hypertensive Disorders Rochester, Minn.
The purpose of this study is to analyze the use of ravulizumab, an inhibitor of complement activation, to target alternative complement pathway in patients with severe preeclampsia/ HELLP syndrome. The goal is to explore the role of ravulizumab as a novel therapy for severe preeclampsia/HELLP syndrome.

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for COVID-19 (RDV-CKD) Rochester, Minn., Jacksonville, Fla. The primary objective of this study is to evaluate whether remdesivir (RDV, GS-5734™) reduces the composite risk of death or invasive mechanical ventilation (IMV) through Day 29 in participants with severely reduced kidney function who are hospitalized for coronavirus disease 2019 (COVID-19).
A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications Including Participants with Resistant Hypertension Rochester, Minn., Scottsdale/Phoenix, Ariz.
The purpose of this study is to evaluate the safety, tolerability and effect of 1 or 2 mg baxdrostat versus placebo, administered once daily (QD) orally, on the reduction of systolic blood pressure in approximately 720 participants aged ≥ 18 years with hypertension, despite a stable regimen of 2 antihypertensive agents at baseline, one of which is a diuretic (uncontrolled hypertension); or ≥ 3 antihypertensive agents at baseline, one of which is a diuretic (treatment-resistant hypertension).